Business Description
Halberd Corp
NAICS : 541714
SIC : 2834
ISIN : US4053311092
Description
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -77.17 | |||||
| Debt-to-Equity | -0.16 | |||||
| Debt-to-EBITDA | -0.34 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1004.26 | |||||
| Beneish M-Score | -85.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.42 | |||||
| 9-Day RSI | 38.96 | |||||
| 14-Day RSI | 39.67 | |||||
| 3-1 Month Momentum % | -33.33 | |||||
| 6-1 Month Momentum % | -54.12 | |||||
| 12-1 Month Momentum % | -15.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 | |||||
| Cash Ratio | 0.01 | |||||
| Days Payable | 87508.75 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -11.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.33 | |||||
| Operating Margin % | -14900 | |||||
| Net Margin % | -15133.33 | |||||
| FCF Margin % | -8033.33 | |||||
| ROA % | -3131.03 | |||||
| ROIC % | -12771.43 | |||||
| ROC (Joel Greenblatt) % | -9933.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -4.87 | |||||
| EV-to-EBITDA | -4.89 | |||||
| EV-to-Revenue | 726.33 | |||||
| EV-to-FCF | -8.91 | |||||
| Earnings Yield (Greenblatt) % | -20.53 | |||||
| FCF Yield % | -12.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HALB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Halberd Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.003 | ||
| EPS (TTM) ($) | -0.001 | ||
| Beta | 0.14 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.34 | ||
| Volatility % | 114.23 | ||
| 14-Day RSI | 39.67 | ||
| 14-Day ATR ($) | 0.000573 | ||
| 20-Day SMA ($) | 0.003428 | ||
| 12-1 Month Momentum % | -15.22 | ||
| 52-Week Range ($) | 0.00235 - 0.0121 | ||
| Shares Outstanding (Mil) | 635.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Halberd Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Halberd Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Halberd Corp Frequently Asked Questions
What is Halberd Corp(HALB)'s stock price today?
The current price of HALB is $0.00. The 52 week high of HALB is $0.01 and 52 week low is $0.00.
When is next earnings date of Halberd Corp(HALB)?
The next earnings date of Halberd Corp(HALB) is .
Does Halberd Corp(HALB) pay dividends? If so, how much?
Halberd Corp(HALB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers